Homocysteine is a naturally occurring amino acid that plays a crucial role in various biochemical processes within the body.
While it is essential for certain functions, elevated levels of homocysteine have been associated with an increased risk of cardiovascular disease, neurodegenerative disorders, and other health issues.
Homocysteine is a sulfur-containing amino acid formed during the metabolism of methionine, an essential amino acid obtained from dietary sources. It exists in two forms: free homocysteine and protein-bound homocysteine.
In the body, homocysteine plays a critical role in methylation reactions, DNA synthesis, and the metabolism of neurotransmitters such as serotonin.
It is involved in the synthesis of cysteine, another amino acid necessary for the production of glutathione, an important antioxidant.
However, elevated levels of homocysteine can be harmful and have been linked to various health conditions.
Understanding homocysteine, its sources, recommended intake, and ways to optimize its levels is vital for maintaining overall health and well-being.
Homocysteine, a non-protein amino acid, is not obtained directly from the diet but instead made inside the body as a byproduct of methionine metabolism. Homocysteine plays a crucial role in the body's metabolism.
Homocysteine can be converted into cysteine or recycled into methionine, an essential amino acid, with the assistance of specific B vitamins.
While some homocysteine is essential for overall health, elevated homocysteine levels have been linked to increased risks of cardiovascular, cerebrovascular, and thromboembolic diseases. However, in many ways the functions of homocysteine in health and disease remain a mystery.
While some studies have shown benefits of lowering homocysteine levels, others have yielded conflicting results regarding its impact on cardiovascular and cerebrovascular risks. [14.]
The metabolism of homocysteine involves various enzymes and B vitamins, and disruptions in this process can lead to elevated levels.
While homocysteine itself can be directly toxic to cells by interfering with protein synthesis and damaging DNA, its elevation is also a marker of dysfunctional metabolism. Many nutritional, hormonal, and genetic factors that raise homocysteine levels are associated with common pathological conditions.
Homocysteine plays a crucial role in the body as a storage molecule for sulfur and a transfer molecule for methyl metabolism. It enables the transfer of single carbon units from the reduced folate pool to the principal methyl donor in the cell.
Low levels of homocysteine, known as hypohomocysteinemia, are associated with metabolic dysfunction and disease. For example, low homocysteine levels are strongly linked to peripheral neuropathy, with 41% of patients with idiopathic peripheral neuropathy exhibiting hypohomocysteinemia. [13.]
Additionally, low homocysteine levels may indicate excessive conversion to cystathione for use in the production of glutathione, taurine, and sulfate, suggesting impaired ability for de novo production of glutathione and increased susceptibility to oxidative stress.
Elevated levels of homocysteine have been associated with various diseases, including cardiovascular disease, cancer, autoimmune diseases, endothelial dysfunction, and neurodegenerative diseases. [13.]
To reduce homocysteine levels, there are three pathways: two for homocysteine remethylation to methionine and one for conversion into cystathione for transsulfuration. The remethylation pathways depend on the folate coenzyme 5-methyltetrahydrofolate and betaine as methyl group donors, while the transsulfuration pathway uses cystathione as a precursor.
Overall, homocysteine plays a crucial role in metabolism, and its levels are tightly regulated. Abnormalities in homocysteine metabolism can lead to various diseases, making it an important marker for metabolic dysfunction and overall health.
Homocysteine levels are commonly assessed in blood plasma or serum; a venipuncture is required to obtain the sample. No special preparation is required.
It is important to consult with the ordering laboratory company for their recommended reference range. Reference ranges vary according to age; typical reference ranges for homocysteine in adults are reported as: [11.]
Adults: 0-12 micromol/L
However, another lab company reports normal values as: [1.]
18 to 60 years: 0.0–14.5 micromol/L
61 to 70 years: 0.0–17.2 micromol/L
71 to 80 years: 0.0–19.2 micromol/L
>80 years: 0.0–21.3 micromol/L
Some experts liken homocysteine to blood glucose: both play a crucial metabolic role, and either excess and deficiency can lead to metabolic and health issues. [13.]
This pattern is common among many body metabolites, which are beneficial within a narrow range but problematic outside it. The real issue arises when these molecules are damaged or present in excessive amounts, leading to physiological alterations.
For homocysteine, the ideal range is estimated to be 5.0 to 7.0 mmol/L. [13.]
Elevated homocysteine levels have been associated with a range of conditions, including hip fracture, cognitive decline, osteoporosis, chronic kidney disease, hypothyroidism, Alzheimer's disease, and schizophrenia. [14.]
Pathophysiologically, elevated homocysteine levels can lead to endothelial injury, inflammation, oxidative stress, and alterations in collagen cross-linking, contributing to atherosclerosis, bone fragility, and neurological disorders. [14., 16.]
Hyperhomocysteinemia
High homocysteine in the blood is also known as hyperhomocysteinemia. Causes of hyperhomocysteinemia include: [1., 10., 14.]
Homocystinuria [8.]
Homocystinuria is a rare genetic disorder characterized by the body's inability to break down the amino acid methionine. This leads to the accumulation of homocysteine and its metabolites in the blood and urine.
Homocystinuria is typically caused by mutations in genes that encode enzymes involved in the metabolism of homocysteine, such as cystathionine beta-synthase (CBS) or methionine synthase (MTR). Symptoms of homocystinuria can vary but often include developmental delays, intellectual disability, eye problems, skeletal abnormalities, and an increased risk of blood clots and heart disease.
Treatment usually involves a special diet low in methionine, along with vitamin B6 supplements and other medications to help lower homocysteine levels. Early diagnosis and management are important to prevent or minimize complications associated with the condition.
Typically lower levels of homocysteine are recommended, as higher homocysteine levels have been associated with an increased risk of disease. [14.]
However, some experts report that a very low level of homocysteine, or hypohomocysteinemia, results in reduced levels of antioxidants, as the sulfur-containing compounds produced as part of homocysteine metabolism are required for glutathione production. [13.]
Hypohomocysteinemia has been associated with idiopathic peripheral neuropathy, Alzheimer’s disease and dementia. [2., 5.]
Reduced levels of homocysteine have also been noted in pregnancy, hormone replacement therapy, and overuse of homocysteine-lowering supplements. [2., 7.]
When testing for homocysteine levels, it can be beneficial to also test for other biomarkers related to cardiovascular health and metabolism. Some of these biomarkers may include:
Currently, elevated homocysteine is a greater problem than low homocysteine.
Individuals with high levels of homocysteine may consider the following:
Low homocysteine: if homocysteine is excessively low, supplementation with methionine, N-acetylcysteine, and taurine is indicated. [13.]
Click here to compare testing options and order testing for homocysteine levels.
[1.] 706994: Homocyst(e)ine | Labcorp. www.labcorp.com. https://www.labcorp.com/tests/706994/homocyst-e-ine
[2.] Bae JB, Han JW, Song J, Lee K, Kim TH, Kwak KP, Kim BJ, Kim SG, Kim JL, Moon SW, Park JH, Ryu SH, Youn JC, Lee DY, Lee DW, Lee SB, Lee JJ, Jhoo JH, Kim KW. Hypohomocysteinemia may increases the risk of dementia and Alzheimer's disease: A nationwide population-based prospective cohort study. Clin Nutr. 2021 Jul;40(7):4579-4584. doi: 10.1016/j.clnu.2021.05.034. Epub 2021 Jun 9. PMID: 34229262.
[3.] Chiocchetti A, Prodam F, Dianzani U. Homocysteine and Folate in Inflammatory Bowel Disease: Can Reducing Sulfur Reduce Suffering? Digestive Diseases and Sciences. 2018;63(12):3161-3163. doi:https://doi.org/10.1007/s10620-018-5274-2
[4.] Craig SA. Betaine in human nutrition. The American Journal of Clinical Nutrition. 2004;80(3):539-549. doi:https://doi.org/10.1093/ajcn/80.3.539
[5.] Cullen CE, Carter GT, Weiss MD, Grant PA, Saperstein DS. Hypohomocysteinemia: a potentially treatable cause of peripheral neuropathology? Phys Med Rehabil Clin N Am. 2012 Feb;23(1):59-65, x. doi: 10.1016/j.pmr.2011.11.001. Epub 2011 Dec 14. PMID: 22239874.
[6.] da Costa KA, Gaffney CE, Fischer LM, Zeisel SH. Choline deficiency in mice and humans is associated with increased plasma homocysteine concentration after a methionine load. Am J Clin Nutr. 2005 Feb;81(2):440-4. doi: 10.1093/ajcn.81.2.440. PMID: 15699233; PMCID: PMC2424020.
[7.] Diaz-Arrastia R. Homocysteine and Neurologic Disease. Archives of Neurology. 2000;57(10). doi:https://doi.org/10.1001/archneur.57.10.1422
[8.] Homocystinuria/Homocysteinemia: Overview, Pathophysiology, Epidemiology. Medscape.com. Published November 10, 2019. https://emedicine.medscape.com/article/1952251-overview
[9.] Kamat PK, Mallonee CJ, George AK, Tyagi SC, Tyagi N. Homocysteine, Alcoholism, and Its Potential Epigenetic Mechanism. Alcohol Clin Exp Res. 2016 Dec;40(12):2474-2481. doi: 10.1111/acer.13234. Epub 2016 Nov 2. PMID: 27805256; PMCID: PMC5133158.
[10.] Kim J, Kim H, Roh H, Kwon Y. Causes of hyperhomocysteinemia and its pathological significance. Arch Pharm Res. 2018 Apr;41(4):372-383. doi: 10.1007/s12272-018-1016-4. Epub 2018 Mar 19. PMID: 29552692.
[11.] Kratz A, Ferraro M, Sluss PM, et al: Case records of the Massachusetts General Hospital: laboratory values. N Engl J Med 2004; 351(15):1549-1563.
[12.] O’Callaghan P, Meleady R, Fitzgerald T, Graham I, European COMAC group. Smoking and plasma homocysteine. European Heart Journal. 2002;23(20):1580-1586. doi:https://doi.org/10.1053/euhj.2002.3172
[13.] Pizzorno J. Homocysteine: Friend or Foe? Integr Med (Encinitas). 2014 Aug;13(4):8-14. PMID: 26770102; PMCID: PMC4566450.
[14.] Son P, Lewis L. Hyperhomocysteinemia. [Updated 2022 May 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554408/
[15.] Verhoef P, Pasman WJ, van Vliet T, Urgert R, Katan MB. Contribution of caffeine to the homocysteine-raising effect of coffee: a randomized controlled trial in humans. The American Journal of Clinical Nutrition. 2002;76(6):1244-1248. doi:https://doi.org/10.1093/ajcn/76.6.1244
[16.] Zhang P, Xie X, Zhang Y. Associations between homocysteine, vitamin B12, and folate and the risk of all-cause mortality in American adults with stroke. Frontiers in nutrition. 2023;10. doi:https://doi.org/10.3389/fnut.2023.1279207
[17.] Zhang Y, Wang Q, Li Q, Lu P. Association between Hyperhomocysteinemia and Thyroid Hormones in Euthyroid Diabetic Subjects. Biomed Res Int. 2015;2015:196379. doi: 10.1155/2015/196379. Epub 2015 Jun 21. PMID: 26180785; PMCID: PMC4491378.